Cyxone recruits key members to the clinical development team
Cyxone today announced that the company has recruited Anna Polak and Levente Dajka as members of the Cyxone development team. Both will bring vast knowledge in clinical trial management, their initial focus will fall primarily on the preparations for the planned phase 2 trial investigating the clinical effect of Rabeximod in rheumatoid arthritis, set to start during 2021.Anna Polak holds a degree in pharmacy from the Medical University of Warsaw and has 15 years of global trial management experience in contract research organizations (CROs), ranging from initial protocol design to final